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Background: Regaining independent ambulation is the top priority for individuals recovering from stroke. Thus,
physical rehabilitation post-stroke should focus on improving walking function and endurance. However, the
amount of walking completed by individuals with stroke attending rehabilitation is far below that required for
independent community ambulation. There has been increased interest in accelerometer-based monitoring of
walking post-stroke. Walking monitoring could be integrated within the goal-setting process for those with
ambulation goals in rehabilitation. The feedback from these devices can be downloaded to a computer to produce
reports. The purpose of this study is to determine the effect of accelerometer-based feedback of daily walking
activity during rehabilitation on the frequency and duration of walking post-stroke.
Methods: Participants will be randomly assigned to one of two groups: feedback or no feedback. Participants will
wear accelerometers daily during in- and out-patient rehabilitation and, for participants in the feedback group, the
participants’ treating physiotherapist will receive regular reports of walking activity. The primary outcome measures
are the amount of daily walking completed, as measured using the accelerometers, and spatio-temporal
characteristics of walking (e.g. walking speed). We will also examine goal attainment, satisfaction with progress
towards goals, stroke self-efficacy, and community-integration.
Discussion: Increased walking activity during rehabilitation is expected to improve walking function and
community re-integration following discharge. In addition, a focus on altering walking behaviour within the
rehabilitation setting may lead to altered behaviour and increased activity patterns after discharge.
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Stroke results in sensorimotor impairments, reduced
balance control, and reduced aerobic function, which
can limit the capacity for independent community am-
bulation [1-3]. Regaining independent ambulation is im-
portant to those with stroke [4,5] and is the most
frequently-reported rehabilitation goal [6,7]. Independ-
ence in walking is important for maintaining autonomy
and quality of life [5,8-10]. Improved functional out-
comes are observed with intense [11-13], task-specific
[14-18] rehabilitation that is delivered relatively early
post-stroke onset [11,16]. Therefore, if a stroke patient
wishes to improve walking ability s/he should do exten-
sive walking practice, particularly early in his/her re-
habilitation. In-patient rehabilitation provides a prime
opportunity for individuals with stroke to practice walk-
ing such that they can ambulate safely post-discharge.
However, the amount of daily walking reportedly com-
pleted by individuals with stroke during in-patient re-
habilitation is low [19-22]. Importantly, the majority of
walking bouts are of short duration (<1 minute)
[19,20,22,23] and typically involve walking to essential
activities (e.g. washroom, dining area, or therapy) [19].Goal N
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Figure 1 Model showing the goal-setting and goal-planning process
broad walking goal upon admission to rehabilitation, such as “I want to be
the patient and determine a more measurable and meaningful goal, such
away from my house”. A short-term sub-goal is then established to help th
walk 100m without stopping”. Following identification of short-term goals,
towards the goal is appraised and feedback is provided to the patient; it is
beneficial. The appraisal will allow therapists and patients to determine if th
be developed. If the sub-goal was not achieved, the physiotherapist may m
are achieved.Goal setting is an essential part of rehabilitation but its
use may be more ‘common sense’ rather than being
grounded in sound psychological theory [24-26]. Scobbie
and colleagues established recommendations for the im-
plementation of goal-setting in rehabilitation based on
three psychological theories (Figure 1): Goal Setting
Theory, Health Action Process Approach, and Social
Cognition Theory [25,27]. Within these recommenda-
tions, appraisal and feedback of performance were iden-
tified as important constructs [27,28]. Providing advice
on health behaviours without objective feedback of com-
pliance or outcomes may lead the patient to develop
“cognitive fantasies”; i.e. belief that they are adhering to
the advice when they are not [29,30]. Feedback of pro-
gress towards goals can increase motivation, improve
self-efficacy and aid action-planning [28].
Researchers have begun to investigate the utility of
ambulatory monitoring using accelerometers [31]. We
developed the Accelerometry for Bilateral Lower Ex-
tremities (ABLE) system to specifically monitor daily
walking activity in individuals with stroke [19,22]. The
ABLE system combines inexpensive ‘off the shelf ’ accel-
erometers with custom written software and providesegotiation
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(modified from Scobbie et al., 2010; [27]. The patient may identify a
able to walk better”. The physiotherapist would discuss this goal with
as “I want to be able to walk my grandson to school, which is 300m
e patient progressively achieve their longer-term goal; i.e. “I want to
a rehabilitation plan is developed and put into action. Progress
at this point in the goal-setting process that accelerometers can be
e sub-goal has been achieved. If so, a more challenging sub-goal may
odify his/her treatment plan. This cycle continues until all goals
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pleted throughout the patients’ day. Therefore, the sys-
tem can provide feedback to the patient or therapist on
not only the total amount of walking completed in the
entire day, but also the duration of each walking bout
(i.e. how long the patient walked continuously) and
times of day when the patient was active or inactive.
Furthermore, by placing accelerometers on both lower
limbs, we can provide information regarding the control
of walking throughout the day (i.e. temporal features of
gait). This information can be provided to the patient
and his/her physiotherapist as part of a goal-setting
process in order to determine whether the patient’s goals
for ambulation are met.
The primary objective of this study is to determine if
feedback about characteristics of daily walking activity,
provided to patients and their treating therapists, will in-
crease walking activity in a group of individuals receiving
rehabilitation post-stroke. We hypothesize that, com-
pared to a control group who do not receive feedback
via the treating physiotherapists, those who receive
accelerometer-based feedback of daily walking activity as
part of a goal-setting process will show: increased total
daily walking activity, as measured by number of steps
per day, total duration of walking activity, and total dis-
tance walked; increased frequency of ‘long’ walking
bouts (i.e. > 5 minutes in duration); and improved con-
trol of walking, as defined by increased self-selected
walking speed, and improved symmetry in spatio-
temporal characteristics of walking. While walking prac-
tice should be initiated during in-patient rehabilitation,
problems with walking function may not be fully appar-
ent until the patient is discharged home. Therefore, we
will examine the effects of accelerometer-based feedback
administered during both in- and out-patient rehabilita-
tion. Under the assumption that accelerometer-based
feedback will increase walking activity, the secondary ob-
jective of this study is to determine if increased walking
activity during rehabilitation results in increased rates of
goal attainment, increased satisfaction with rehabilita-
tion, improved self-efficacy, and improved community
re-integration post-discharge from rehabilitation.
Methods
Design overview
This is a single-blind randomized controlled trial with
the assessor being blinded to the group allocation
(participants cannot be blinded to group allocation).
Participants will be randomly assigned, using allocation
concealment, to one of two groups: feedback or no feed-
back. The study will span three phases of rehabilitation
and recovery post-stroke: in-patient rehabilitation, out-
patient rehabilitation, and post-rehabilitation community
reintegration. Outcome measures will be obtained at upto four time points (Figure 2): 1) upon entry into the
study; 2) immediately prior to discharge from in-patient
rehabilitation; 3) immediately prior to discharge from
out-patient rehabilitation (for those admitted to out-
patient rehabilitation at the institution); and 4) three
months following discharge from rehabilitation. This
study was approved by the University Health Network
research ethics board (protocol number 11-027-DE).
Participants
Individuals with sub-acute stroke who are attending in-
patient rehabilitation at Toronto Rehab will be recruited
to this study and will provide written informed consent
prior to participating. All participants will have identified
improving walking function as a rehabilitation goal upon
admission and will be able to walk without supervision
at the time of recruitment into the study. Individuals un-
able to provide consent to participate in the study due
to foreign language or cognitive impairment will be ex-
cluded. In order to ensure generalizability to the wider
stroke population, no further exclusion criteria will be
applied.
Group allocation and blinding
Participants will be assigned using a blocked stratified
randomization approach to one of two groups: 1) feed-
back of walking activity; or 2) no feedback of walking ac-
tivity (i.e. control group). There will be two strata based
on the factor walking speed. Walking speed predicts the
level of community ambulation achieved following dis-
charge from rehabilitation [5]. A threshold walking
speed of 0.42 m/s has been found to be predictive of
community ambulation post-stroke [32]; therefore, par-
ticipants will be stratified according to self-selected
walking speed (slow walkers: <0.42 m/s; moderate-fast
walkers: ≥0.42 m/s). Stratification will help to ensure
that the two groups do not differ significantly on this
factor [33,34] and that there will be approximately equal
numbers of participants assigned to each group. The
block size within strata will be four participants.
Group allocation will be performed by the principal in-
vestigator. A computer-generated random sequence will
be used to assign participants. The treating physiothera-
pists will administer the goal-setting/planning (including
feedback, if appropriate). A blinded research assistant
will conduct the assessments and process data. Partici-
pants cannot be blinded to group allocation and will be
informed of the chance of being allocated to one of two
groups.
Current practice for goal setting and goal planning at
Toronto Rehab
Goal setting and planning form an important part of
care at Toronto Rehab. Goal setting is a patient-centred
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Figure 2 Participant flowchart. The study will span three phases of rehabilitation and recovery post-stroke: in-patient rehabilitation, out-patient
rehabilitation, and post-rehabilitation community re-integration. Patients will be assessed for eligibility upon admission to in-patient rehabilitation
and throughout their stay. Upon providing consent, participants will be assigned to either the feedback or no feedback group. Participants who
are discharged to out-patient rehabilitation at one of Toronto Rehab sites will continue to complete the schedule of goal-planning for walking
activity either with or without feedback (depending upon group allocation).
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admission to rehabilitation, the patient discusses goals
with the interprofessional care team. Goals identified at
this stage of care might be broad; e.g. “I want to be able
to walk better”. Through discussion, the team explores
the relationship of the individual’s goal and the impact
of their condition within the context of participation andimportant life roles; e.g. “I want to be able to continue
to provide childcare to my grandson, including walking
him to school.” This part of the goal-setting and plan-
ning process is often termed ‘goal negotiation’ [27]. The
individual therapists then work with the patient to iden-
tify specific and challenging [24,28] sub-goals at the ac-
tivity or impairment level that would lead to progressive
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walk 100m without stopping”. Each individual therapist
then bases their therapeutic intervention on the patient’s
identified goals. The goal coordinator, who is a member
of the interprofessional team, meets with the patient
once every two weeks to discuss progress towards all of
his/her goals. Each individual therapist also meets with
the patient routinely during daily therapy sessions to dis-
cuss progress relevant to his/her practice; i.e. physiother-
apists would discuss progress towards walking goals
with patients on a regular basis. During either the fort-
nightly meetings with the goal coordinator, or discus-
sions with the patient’s therapists, sub-goals may be re-
evaluated depending upon how the patient is progressing
towards his/her goals; e.g. a more challenging goal may
be set if previous sub-goals have been achieved. Specific
goals are documented for each patient in the clinical
chart. Throughout rehabilitation and at the time of dis-
charge, the individual therapist or goal coordinator de-
termines if the patient’s goals were achieved (see
Figure 1).The ABLE system – description, on-going development
and pilot implementation
The ABLE system consists of two lightweight commercially-
available triaxial accelerometers (Figure 3; Model X16-1C or
X6-2mini, Gulf Data Concepts, LLC., Waveland, Mississippi,
USA). The accelerometers are ‘self-recording’, such that data
are stored directly on an internal microSD card without the
need for an external data logger [19,37]. The accelerometers
are affixed just above the ankles of both limbs using a
breathable foam wrap that is Velcro® hook receptive (Pro
Wrap, Fabrifoam, Exton, Pennsylvania, USA). The acceler-
ometers record acceleration in three axes for the entire
monitoring period in blocks of eight hours at 40 Hz. Our
previous work [19] confirms that these parameters are suffi-
cient for the purpose of whole-day ambulatory monitoring.
Participants are instructed to only remove the accelerome-
ters before going to sleep at night (to prevent discomfort),A B
Figure 3 The ABLE accelerometers. The ABLE accelerometer as affixed to
panel A, the accelerometer is exposed to show its size. In panel B, the acce
accelerometers are affixed in practice.when showering, and when required to do so for medical
testing (e.g. magnetic resonance imaging).
Data are transferred from the accelerometers and
processed using a custom-written algorithm [19] (MatLab,
The Mathworks, Natick, Massachusetts, USA). The raw
acceleration data are high-pass filtered at 0.25 Hz to re-
move the gravity component [38] and low-pass filtered at
either 5 Hz for the purpose of step detection or 10 Hz to
detect the temporal features of each step (i.e. heel strike
and toe off) [19]. A bout of walking is defined by at least 4
consecutive steps with <10 s between steps; if there is a
pause of 10 s or more between steps a new bout is identi-
fied. The following measures are calculated for each walk-
ing bout: number of steps taken, total bout duration,
average cadence (steps per minute), and average swing
duration (heel strike minus toe off) for each limb. Heel-
strike and toe-off detection has previously been validated
against foot-switches [19]. On-going development aims to
determine the validity of calculating step length, walking
speed and distance walked for each bout.
Intervention
Participants will be recruited into the study when they
are deemed to be ambulatory without supervision. Pa-
tients with stroke tend to be discharged from in-patient
rehabilitation 2–4 weeks after they reach this status.
Therefore, the length of the in-patient intervention
phase will vary between participants but will be approxi-
mately 2–4 weeks long. Out-patient rehabilitation ser-
vices are offered in three blocks of 4–6 weeks duration;
the first block is 6-weeks long to allow extra time for as-
sessment prior to prescription of rehabilitation services.
Participants in this study will be followed only for the
first and second (if applicable) block of out-patient re-
habilitation. The third block is often either not com-
pleted at all or not completed immediately subsequent
to the second block (i.e. there may be a gap of a number
of months between the second and third block). There-
fore, the duration of the out-patient phase of the inter-
vention is 6–10 weeks.the ankle above the lateral malleolus. Model X6-2mini is shown. In
lerometer is covered by the foam wrap; this is how the
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the intervention in a consistent manner, we will host a
series of in-services concerning goal-planning of walking
activity. These in-services will focus specifically on the
output from the ABLE system, which is the new compo-
nent of this study. Physiotherapists will learn how to in-
terpret the output from the ABLE system and how to
use this information to evaluate a patient’s progress to-
wards their goals. Specific cases will be discussed based
on pilot testing of ambulatory monitoring.In-patient rehabilitation phase
Participants in both intervention groups will meet with
their primary treating physiotherapist once per week to
discuss progress towards their goals for rehabilitation
that are relevant to physiotherapy, including goals for
walking. All participants will wear the accelerometers
every weekday during in-patient rehabilitation to moni-
tor daily walking activity. Research personnel will meet
with the patients each morning to ensure that the accel-
erometers are worn correctly.
For those participants assigned to the feedback group,
physiotherapists will receive a daily summary of patients’
walking activity as a tool to guide goal planning. Physiother-
apists will use the information as a ‘homework checker’ to
determine if patients are complying with an assigned walk-
ing program. In the case of non-compliance, the physiother-
apist will discuss a coping strategy for better integrating
walking activity into the patients’ day. In the event that the
patient is meeting their specific sub-goals for walking activ-
ity, the physiotherapist will re-evaluate these sub-goals and
suggest more challenging goals.
For participants assigned to the control group, physio-
therapists will not receive accelerometer-based feedback
of daily walking activity. However, physiotherapists will
still discuss the achievement of walking goals with their
patient. The same strategies implemented in the feed-
back group will be implemented in the control group
(i.e. action plans, coping strategies, re-evaluation of goals).
This process is no different to usual care around goal
planning at Toronto Rehab.Out-patient rehabilitation phase
Participants in both groups will meet with their primary
treating physiotherapist regularly to discuss progress to-
wards walking goals. All participants will wear the accel-
erometers daily during out-patient rehabilitation. For
those in the feedback group, physiotherapists will receive
a weekly summary of patients’ walking activity as a tool
to guide goal planning. Participants in the control group
will attend goal-planning meetings with their physiother-
apists, as is usual care.Measures
A summary of the measures collected at each point in
the study is included in Table 1.
Cohort descriptors – demographics, medical & stroke
history, and measures of physical function
The following demographic and medical information will
be obtained from clinical charts on admission to re-
habilitation in order to characterize the study cohort:
age, sex, height, weight, date of stroke onset, lesion loca-
tion, pre-morbid medical history & current medical con-
ditions, prescription medications, the National Institutes
of Health Stroke Scale (NIH-SS) [39], the Chedoke-
McMaster Stroke Assessment (CMSA) [40] foot and leg
scores, Berg Balance Scale (BBS) [41], and the Activity-
specific Balance Confidence (ABC) questionnaire [42].
The NIH-SS is an 11-item scale that provides a gross
measure of the effects and severity of stroke. The NIH-
SS has shown good intra-rater (intraclass correlation co-
efficients; ICCs = 0.93) and inter-rater (ICCs = 0.95) reli-
ability [43]. The CMSA assigns a score according to the
level of motor recovery in the foot and leg and is fre-
quently used to evaluate level of motor recovery post-
stroke in clinical settings. The CMSA foot and leg scores
have good intra-rater (ICCs = 0.94-0.98) and inter-rater
(ICCs = 0.85-0.96) reliability [40]. The BBS is a 14-item
observational rating scale that provides a measure of
functional balance. Participants are asked to perform
each of the 14 tasks and their ability to perform the task
is rated on a scale from 0–4. The BBS shows good in-
ternal consistency (Cronbach’s α=0.92-0.98) and good
inter-rater (ICCs = 0.95-0.98), intra-rater (ICCs = 0.97)
and test-retest (ICC = 0.98) reliability post-stroke [44].
The ABC is a 16-item questionnaire that asks individuals
to rate confidence performing various daily activities.
The ABC shows good internal consistency (Cronbach’s
α=0.94) and test-retest reliability (ICC = 0.85) in individ-
uals post-stroke [45].
In addition to collection at admission to rehabilitation,
medical conditions will be reviewed at all assessment
time points to confirm that there have been no major
changes in medical status between assessments. The
CMSA, BBS, and ABC will be repeated at discharge
from in-patient and out-patient rehabilitation as im-
paired balance control, impaired lower-limb function
and reduced balance confidence could potentially be
barriers to independent ambulation. The occurrence of
falls will be documented for safety monitoring purposes.
Primary outcomes – daily walking activity & control of
walking
The primary outcome measures pertain to walking activ-
ity as averaged over three days around the first two as-
sessment time points (i.e. enrolment into the study and
Table 1 Measures collected at the assessment time points
Time 1: study
enrolment
Time 2: discharge from in-
patient rehabilitation
Time 3: discharge from out-
patient rehabilitation




Medical conditions ✓ ✓ ✓ ✓








National Institutes of Health
Stroke Scale
✓






✓ ✓ ✓ ✓







Barriers to walking interview ✓ ✓ ✓ ✓
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days before the last assessment time point (discharge
from out-patient rehabilitation). A longer monitoring
period will be used for the out-patient phase as patients
have more options for mobility post-discharge. Sum-
mary, whole day, outcome measures will be used in the
analysis; i.e. total walking duration, total number of steps
taken and total distance walked. However, it is most
relevant to community ambulation and aerobic fitness to
show increased duration of continuous walking [46,47];
therefore, we will also calculate the frequency and
duration of longer walking bouts (i.e. >5 minutes con-
tinuously). Furthermore, intensity of walking is also
important for cardiovascular benefit; therefore we will
determine the frequency and duration of ‘high inten-
sity’ walking, defined by either a walking speed or
cadence ≥ 85% of maximum walking velocity.
Increased walking practice should improve control of
walking. Spatio-temporal features of self-selected walk-
ing will be measured using a 4 m-long pressure sensitive
mat (GAITRite, CIR Systems, Inc, Havertown, Pennsyl-
vania, USA). Participants will start walking at least 1 m
away from the mat and will be instructed to walk across
the mat until they reach a mark 1 m from the end of the
mat. Participants will be instructed to walk at their nor-
mal pace. Participants will complete three passes across
the mat and measures will be averaged across the threepasses. Walking speed, cadence, step length, and sym-
metry of spatio-temporal measures [48] will be calcu-
lated. While it is possible to determine these measures from
the daily walking activity collected using the ABLE system,
standardized assessment is required for pre- to post-
intervention comparison of spatio-temporal measures.
Secondary outcomes – self- efficacy, community
integration, goal attainment, satisfaction & barriers
The Stroke Self-Efficacy Questionnaire (SEQ) [49] will
be used to measure stroke-specific self-efficacy. This 13-
item questionnaire asks participants to rate confidence
in completing various tasks, including walking indoors
and outdoors and exercising, on a scale from 0–10. This
questionnaire shows good test-retest reliability (ICCs >
0.87) [50], internal consistency, and criterion validity
and can discriminate between patients who are inde-
pendently ambulating and those who are not [49].
The Community Integration Questionnaire (CIQ) will
be used as a measure of integration and participation
post-discharge from in- and out-patient rehabilitation
[51,52] and has been used often in stroke research
[53-56]. This is a 15-item questionnaire that evaluates
integration into the community in three domains: home,
social, and productive activities (e.g. employment or vol-
unteer activities). Researchers have developed a version
of the CIQ specifically for individuals with aphasia and
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retest reliability in the post-stroke population (ICC =
0.96) [55].
Goal attainment will be determined from patient charts at
discharge from both in-patient and out-patient rehabilita-
tion. Goals are classified ‘achieved’, ‘partially achieved’, ‘not
completed’, or ‘discontinued’. Satisfaction with progress to-
wards goals will also be extracted from patient charts (rated
on a 10-point scale). We will interview patients in order to
determine barriers to walking. A single open-ended question
will be used: “what, if anything, do you think is preventing
you from walking more than you are at the moment?”.
Statistical analyses and sample size
The following potentially confounding measures will be
compared between the two intervention groups: CMSA,
BBS, NIH-SS, ABC, and length of stay (in-patient rehabilita-
tion). Measures that differ significantly between the two
groups will be included as covariates in statistical models
comparing interventions. Repeated-measures analysis of
variance (ANOVA) or analysis of covariance (ANCOVA; as
appropriate), with group-by-time interaction, will be used to
evaluate the effect of the interventions on walking activity,
spatio-temporal characteristics of walking, and SEQ. Separ-
ate ANOVAs will be used for each outcome measure. The
‘group’ term is the intervention group; the ‘time’ term is the
assessment time point. The group-by-time interaction effect
will reveal if there is a greater change over time in one group
compared with the other. Separate analyses will be
conducted to compare measures at the first three time
points; i.e. discharge from in-patient will be compared to
study enrolment, and discharge from out-patient will be
compared to discharge from in-patient. One-way ANOVA
or ANCOVA will be used to compare the CIQ and satisfac-
tion between the two groups at discharge from rehabilitation
and three months post-discharge from in-patient. The fre-
quency of goal attainment between the two groups will be
compared at discharge from both in-patient and out-patient
rehabilitation; intent-to-treat analysis will be employed for
this outcome for all participants initially randomized, includ-
ing those who withdraw from the study [24,57]. Barriers to
walking will be documented.
For sample size estimates, we used change in total
walking duration from the initial assessment to dis-
charge from in-patient rehabilitation (i.e. the first phase
of the study) as our primary outcome of interest. In our
pilot work, we observed an average increase in total daily
walking activity of 20 minutes from the initial assess-
ment to discharge in a group of stroke in-patients. We
expect that an average increase in daily walking activity
of 40 minutes in the feedback group would be clinically
meaningful (i.e. 20 minutes more than expected with no
feedback). The standard deviation for change in daily
walking time was 23 minutes in our pilot work. Using asample size formula for repeated measures ANOVA
[58], an improvement of 20 minutes of walking more in
the feedback group than the no feedback group, a stand-
ard deviation of 23 minutes, a probability of a Type I
error of 0.05 and probability of Type II error of 0.1, 28
individuals per group will be required in the final ana-
lysis. In order to achieve a final sample of 56 (i.e. 28 per
group) we will aim to recruit approximately 62 partici-
pants (i.e. assuming that approximately 10% of partici-
pants will withdraw from the study). Sample size and
power estimates using an updated standard deviation
will be reassessed after the first 12 participants have
completed the first phase of the study, as per CONSORT
recommendations [59,60].Discussion
While there has been interest in using accelerometers
for walking-related goal-setting and goal-planning in re-
habilitation, the effectiveness of this technology in clin-
ical practice to improve walking activity has not been
shown. This study may demonstrate that accelerometer-
based feedback of walking activity can increase walking
activity, improve walking outcomes, and potentially im-
prove community re-integration following discharge
from stroke-rehabilitation. The study design deliberately
integrates the novel intervention into current practice;
therefore, the results will be immediately generalizable
to other stroke rehabilitation settings.
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